Mandate

Vinge has advised EQT AB (publ) in connection with the entry into of a EUR 1,000,000,000 revolving credit facility agreement.

December 22, 2020 Banking and Finance

The financing is intended to be used for EQT’s general corporate purposes, including supporting its growth initiatives and long-term strategy.

The agreement contains a possibility to connect pricing to EQT’s compliance with certain ESG-targets. The financing was arranged by Nordea and SEB and the syndicate of banks contained 13 global financial institutions.

The Vinge team primarily consisted of Louise Brorsson Salomon, Ludvig Wettergren och Rebecka Målquist.

 

Related

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of their production facility in Uppsala to Ofichem. The Uppsala site specializes in small-scale, early-phase development work.
August 13, 2025

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025